Blocking Sympathetic Nervous System Reverses Partially Stroke-Induced Immunosuppression but does not Aggravate Functional Outcome After Experimental Stroke in Rats

Neurochemical Research

Volumn 41, Issue 8, 2016, Pages 1877-1886

  Deng, Qi Wen ^a   Yang, Heng ^a   Yan, Fu Ling ^a   Wang, Huan ^a   Xing, Fang Lan ^a   Zuo, Lei ^a   Zhang, Han Qing ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Immunosuppression; Nuclear factor B; Stroke; Sympathetic nervous system; Arrestin2

Indexed keywords

BETA ARRESTIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDOPAMINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EXPERIMENTAL STROKE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS ASSESSMENT; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SYMPATHETIC TONE; T LYMPHOCYTE ACTIVATION; ANIMAL; CONVALESCENCE; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; IMMUNOSUPPRESSION; MALE; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; STROKE; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 84964048371     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-016-1899-8     Document Type: Article

References (50)

1. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW (2003) The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 60(4):620–625
2. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C et al (2000) Medical complications after stroke: a multicenter study. Stroke 31(6):1223–1229
3. Koennecke HC, Belz W, Berfelde D, Endres M, Fitzek S, Hamilton F et al (2011) Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology 77(10):965–972. doi:10.1212/WNL.0b013e31822dc795
4. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gomez-Choco M et al (2007) Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci 252(1):29–35. doi:10.1016/j.jns.2006.10.001
5. Meisel C, Meisel A (2011) Suppressing immunosuppression after stroke. N Engl J Med 365(22):2134–2136. doi:10.1056/NEJMcibr1112454
6. Wong CH, Jenne CN, Lee WY, Leger C, Kubes P (2011) Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334(6052):101–105. doi:10.1126/science.1210301
7. Hattori Y, Moriwaki A, Hori Y (1990) Biphasic effects of polarizing current on adenosine-sensitive generation of cyclic AMP in rat cerebral cortex. Neurosci Lett 116(3):320–324
8. Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U et al (2011) Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol 10(5):471–480. doi:10.1016/S1474-4422(11)70066-7
9. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U (2005) Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 6(10):775–786. doi:10.1038/nrn1765
10. Woiciechowsky C, Schoning B, Lanksch WR, Volk HD, Docke WD (1999) Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med (Berl). 77(11):769–780
11. Czlonkowska A, Cyrta B, Korlak J (1979) Immunological observations on patients with acute cerebral vascular disease. J Neurol Sci 43(3):455–464
12. Chamorro A, Urra X, Planas AM (2007) Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38(3):1097–1103. doi:10.1161/01.STR.0000258346.68966.9d
13. Klehmet J, Harms H, Richter M, Prass K, Volk HD, Dirnagl U et al (2009) Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 158(3):1184–1193. doi:10.1016/j.neuroscience.2008.07.044
14. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T et al (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198(5):725–736. doi:10.1084/jem.20021098
15. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958–969. doi:10.1038/nri2448
16. Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11(11):750–761. doi:10.1038/nri3088
17. Barron L, Wynn TA (2011) Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am J Physiol Gastrointest Liver Physiol 300(5):G723–G728. doi:10.1152/ajpgi.00414.2010
18. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3(1):23–35. doi:10.1038/nri978
19. Ivashkiv LB (2011) Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur J Immunol 41(9):2477–2481. doi:10.1002/eji.201141783
20. Alvira CM (2014) Nuclear factor-kappa-B signaling in lung development and disease: one pathway, numerous functions. Birth Defects Res A Clin Mol Teratol 100(3):202–216. doi:10.1002/bdra.23233
21. Gao H, Sun Y, Wu Y, Luan B, Wang Y, Qu B et al (2004) Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol Cell 14(3):303–317
22. Grailer JJ, Haggadone MD, Sarma JV, Zetoune FS, Ward PA (2014) Induction of M2 regulatory macrophages through the beta2-adrenergic receptor with protection during endotoxemia and acute lung injury. J Innate Immun 6(5):607–618. doi:10.1159/000358524
23. Feibel JH, Hardy PM, Campbell RG, Goldstein MN, Joynt RJ (1977) Prognostic value of the stress response following stroke. JAMA 238(13):1374–1376
24. Yan FL, Zhang JH (2014) Role of the sympathetic nervous system and spleen in experimental stroke-induced immunodepression. Med Sci Monit 20:2489–2496. doi:10.12659/MSM.890844
25. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1):84–91
26. Gerriets T, Stolz E, Walberer M, Muller C, Kluge A, Bachmann A et al (2004) Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke 35(2):566–571. doi:10.1161/01.STR.0000113692.38574.57
27. Wang J, Yu L, Jiang C, Fu X, Liu X, Wang M et al (2015) Cerebral ischemia increases bone marrow CD4+ CD25+ FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Brain Behav Immun 43:172–183. doi:10.1016/j.bbi.2014.07.022
28. Wirth T, Westendorf AM, Bloemker D, Wildmann J, Engler H, Mollerus S et al (2014) The sympathetic nervous system modulates CD4(+)Foxp3(+) regulatory T cells via noradrenaline-dependent apoptosis in a murine model of lymphoproliferative disease. Brain Behav Immun 38:100–110. doi:10.1016/j.bbi.2014.01.007
29. Zhang DP, Yan FL, Xu HQ, Zhu YX, Yin Y, Lu HQ (2009) A decrease of human leucocyte antigen-DR expression on monocytes in peripheral blood predicts stroke-associated infection in critically-ill patients with acute stroke. Eur J Neurol 16(4):498–505. doi:10.1111/j.1468-1331.2008.02512.x
30. Reddy DB, Reddanna P (2009) Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages. Biochem Biophys Res Commun 381(1):112–117. doi:10.1016/j.bbrc.2009.02.022
31. Lee KW, Lee Y, Kim DS, Kwon HJ (2006) Direct role of NF-kappaB activation in Toll-like receptor-triggered HLA-DRA expression. Eur J Immunol 36(5):1254–1266. doi:10.1002/eji.200535577
32. Failli V, Kopp MA, Gericke C, Martus P, Klingbeil S, Brommer B et al (2012) Functional neurological recovery after spinal cord injury is impaired in patients with infections. Brain 135(Pt 11):3238–3250. doi:10.1093/brain/aws267
33. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B (2001) Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology 57(5):833–838
34. Meyer JS, Stoica E, Pascu I, Shimazu K, Hartmann A (1973) Catecholamine concentrations in CSF and plasma of patients with cerebral infarction and haemorrhage. Brain 96(2):277–288
35. Sander D, Klingelhofer J (1995) Changes of circadian blood pressure patterns and cardiovascular parameters indicate lateralization of sympathetic activation following hemispheric brain infarction. J Neurol 242(5):313–318
36. Becker KJ, Kindrick DL, Lester MP, Shea C, Ye ZC (2005) Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J Cereb Blood Flow Metab 25(12):1634–1644. doi:10.1038/sj.jcbfm.9600160
37. Bornstein NM, Aronovich B, Korczyn AD, Shavit S, Michaelson DM, Chapman J (2001) Antibodies to brain antigens following stroke. Neurology 56(4):529–530
38. Dambinova SA, Khounteev GA, Izykenova GA, Zavolokov IG, Ilyukhina AY, Skoromets AA (2003) Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem 49(10):1752–1762
39. Kleinschnitz C, Schwab N, Kraft P, Hagedorn I, Dreykluft A, Schwarz T et al (2010) Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 115(18):3835–3842. doi:10.1182/blood-2009-10-249078
40. Romer C, Engel O, Winek K, Hochmeister S, Zhang T, Royl G et al (2015) Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke. J Neurosci 35(20):7777–7794. doi:10.1523/JNEUROSCI.1532-14.2015
41. Hauben E, Nevo U, Yoles E, Moalem G, Agranov E, Mor F et al (2000) Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355(9200):286–287
42. Lewitus GM, Kipnis J, Avidan H, Ben-Nun A, Schwartz M (2006) Neuroprotection induced by mucosal tolerance is epitope-dependent: conflicting effects in different strains. J Neuroimmunol 175(1–2):31–38. doi:10.1016/j.jneuroim.2006.02.013
43. Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC et al (1997) Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci USA 94(20):10873–10878
44. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5(1):49–55. doi:10.1038/4734
45. Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC et al (2002) Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci 22(7):2690–2700
46. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B (1994) Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265(5168):106–109
47. Baldwin AS Jr (2001) Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107(1):3–6. doi:10.1172/JCI11891
48. Baldwin AS Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649–683. doi:10.1146/annurev.immunol.14.1.649
49. van der Poll T, Jansen J, Endert E, Sauerwein HP, van Deventer SJ (1994) Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 62(5):2046–2050
50. Feng D, Ling WH, Duan RD (2010) Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages. Inflamm Res 59(2):115–121. doi:10.1007/s00011-009-0077-8